AXS Investments Launches First-Ever U.S. Suite of Single-Stock Leveraged Bull and Bear ETFs
by Fred Fuld III
Recently I wrote an article called 10 Ways to Make Money in a Bear Market. Well, now there is an additional way. You can now buy a single stock bearish ETF for certain stocks.
AXS Investments, a leading asset manager providing access to alternative investments for growth, income and diversification, today, July 14, 2022, launched a suite of eight ETFs that seek to provide leveraged long or inverse exposure to the daily performance of some of the most actively traded stocks across a variety of sectors.
“We are thrilled to be the first firm to bring single-stock leveraged and inverse ETFs to U.S. investors,” said Greg Bassuk, CEO of AXS Investments. “With the launch of this highly innovative family of ETFs, AXS has once again opened new access for traders and sophisticated investors, namely to express their high-conviction views on some of the most actively traded single stocks, regardless of whether their sentiment is bullish or bearish. AXS is excited to continue our aggressive build-out of highly differentiated ETFs designed to provide investors with unique, first-of-their-kind investments to achieve their varying objectives.”
The initial suite of AXS single-stock ETFs provides investors with leveraged long (“Bull”) and short (“Bear”) daily exposure to the following stocks:
• Tesla: AXS TSLA Bear Daily ETF (TSLQ)
• NVIDIA: AXS 1.25X NVDA Bear Daily ETF (NVDS)
• PayPal: AXS 1.5X PYPL Bull Daily ETF (PYPT) and AXS 1.5X PYPL Bear Daily ETF (PYPS)
• Nike: AXS 2X NKE Bull Daily ETF (NKEL) and AXS 2X NKE Bear Daily ETF (NKEQ)
• Pfizer: AXS 2X PFE Bull Daily ETF (PFEL) and AXS 2X PFE Bear Daily ETF (PFES)
As you can see, some of these ETFs have a leveraged bearish goal, such as Pfizer, which has a goal of providing two times the inverse of the daily performance of the price of the stock.
AXS Continues to Expand Fund Lineup with Fast-Growing Suite of First-of-Their-Kind Strategies.
Today’s rollout of these new ETFs is just one of many major strategic growth initiatives successfully achieved by AXS.
“Whether it is powerful inflation fighting tools, ways to express views on innovation, or a host of other novel investments that previously were unavailable to investors, our goal remains to be the leader in providing investors with access to the tools needed to build portfolios and to trade effectively in today’s volatile markets,” continued Bassuk. “We’re very excited about today’s news, and all that we still have in our product pipeline for 2022 and beyond.”